CDER Review Overhaul Will Include Input From Foreign Reviewers
This article was originally published in The Tan Sheet
FDA's Center for Drug Evaluation & Research will invite input from foreign drug regulators as part of a planned revamping of its NDA review process, CDER Director Janet Woodcock, MD, indicated at a seminar for center staff Sept. 15.
You may also be interested in...
The new Quality Assurance Unit in FDA's Center for Drug Evaluation & Research will be called upon to hold internal workshops and educational sessions to highlight well-conducted drug reviews and to update CDER medical officers on review "best practices."
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands